Reflecting on the extra revenue been brought in while doing the renal trial. A novel thought getting paid for doing trials instead of paying out SH funds.
As I understand the former CEO did not embrace this avenue and those familiar with the trials are no longer work with the company.
Management changes etc former CEO & board.
Potentially another revenue stream paid for by the either of the 2 big Renal players to continue the research while policy and sales improve for SOZO BCRL. Just staying because it was asked.
Sales rep left under RV watch that's the only one formally mentioned.
I don't know about California, if reps have left, if so what was the time frame. Maybe Lisa P is the rep for CA and her former position needs to be filled? her degree is from UoC. I think backfill was mentioned by MG so that would explain CA, it's the most populism state would require 2 reps.
"
What we do know is there are 10 sale reps, I think they are called Account Managers, they don't manage other employees, they just manage the sales to the clients "start to finish" and 6 people on the implementation team working on the market leads.
Long standing personal are in charge of those teams.
Lisa Prom - Vice President sales joined Impedimed 2011.
Joann Yao - CSO joined Impedimed 2019.
A lot of knowledge there directly related to sales and customer networks. What a great chance for new CA sale reps to be mentored by LP.
There are others in the management Team that have been there a very long time refer to web site.
That should about cover those employee concerns.
Kind regards
Acclivity
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
Reflecting on the extra revenue been brought in while doing the...
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.4¢ |
Change
0.004(5.00%) |
Mkt cap ! $169.9M |
Open | High | Low | Value | Volume |
8.1¢ | 8.4¢ | 8.0¢ | $256.5K | 3.159M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 121194 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.082 |
1 | 150000 | 0.081 |
1 | 410927 | 0.080 |
4 | 205768 | 0.079 |
4 | 383448 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 121194 | 2 |
0.088 | 28888 | 1 |
0.089 | 50000 | 1 |
0.090 | 53691 | 2 |
0.092 | 100000 | 1 |
Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
Last
8.3¢ |
  |
Change
0.004 ( 3.75 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.4¢ | 7.9¢ | 1002631 | ||
Last updated 15.59pm 15/05/2024 ? |
Featured News
IPD (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online